ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$186.71−3.65 (-1.92%)
Close on Nov 20, 2026Market cap $14.30BP/E 32.1Yield –
ICON gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
ICON's gross profit for the twelve months ending Sep 30, 2026 was $1.93B, down 17.1% year over year. For fiscal 2025 it was $2.18B, down 8.2% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $2.37B in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18B | -8.2% |
| FY2024 | Dec 31, 2024 | $2.37B | +0.9% |
| FY2023 | Dec 31, 2023 | $2.35B | +6.1% |
| FY2022 | Dec 31, 2022 | $2.21B | +46.8% |
| FY2021 | Dec 31, 2021 | $1.51B | +84.5% |
| FY2020 | Dec 31, 2020 | $817.41M | -1.7% |
| FY2019 | Dec 31, 2019 | $831.70M | +7.0% |
| FY2018 | Dec 31, 2018 | $777.56M | +6.4% |
| FY2017 | Dec 31, 2017 | $731.13M | +3.7% |
| FY2016 | Dec 31, 2016 | $705.15M | +5.9% |
| FY2015 | Dec 31, 2015 | $666.00M | +11.0% |
| FY2014 | Dec 31, 2014 | $600.15M | +22.3% |
| FY2013 | Dec 31, 2013 | $490.65M | +23.5% |
| FY2012 | Dec 31, 2012 | $397.26M | +19.0% |
| FY2011 | Dec 31, 2011 | $333.81M | -6.9% |
| FY2010 | Dec 31, 2010 | $358.66M | -5.6% |
| FY2009 | Dec 31, 2009 | $379.83M | +1.0% |
| FY2008 | Dec 31, 2008 | $376.01M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $491.83M | -9.8% |
| Q2 FY2026 | Jun 30, 2026 | $479.29M | -17.8% |
| Q1 FY2026 | Mar 31, 2026 | $477.93M | -15.6% |
| Q4 FY2025 | Dec 31, 2025 | $480.74M | -24.0% |
| Q3 FY2025 | Sep 30, 2025 | $545.46M | -10.4% |
| Q2 FY2025 | Jun 30, 2025 | $583.33M | +5.4% |
| Q1 FY2025 | Mar 31, 2025 | $566.06M | -1.7% |
| Q4 FY2024 | Dec 31, 2024 | $632.74M | +5.7% |
| Q3 FY2024 | Sep 30, 2024 | $608.55M | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | $553.67M | -4.8% |
| Q1 FY2024 | Mar 31, 2024 | $575.97M | +0.4% |
| Q4 FY2023 | Dec 31, 2023 | $598.49M | +3.0% |
| Q3 FY2023 | Sep 30, 2023 | $594.57M | +4.9% |
| Q2 FY2023 | Jun 30, 2023 | $581.80M | +7.1% |
| Q1 FY2023 | Mar 31, 2023 | $573.89M | +9.7% |
| Q4 FY2022 | Dec 31, 2022 | $581.32M | +10.1% |
| Q3 FY2022 | Sep 30, 2022 | $566.59M | +11.4% |
| Q2 FY2022 | Jun 30, 2022 | $543.13M | +126.3% |
| Q1 FY2022 | Mar 31, 2022 | $523.30M | +125.6% |
| Q4 FY2021 | Dec 31, 2021 | $527.82M | +134.7% |
| Q3 FY2021 | Sep 30, 2021 | $508.41M | +144.1% |
| Q2 FY2021 | Jun 30, 2021 | $240.03M | +37.6% |
| Q1 FY2021 | Mar 31, 2021 | $231.95M | +10.6% |
| Q4 FY2020 | Dec 31, 2020 | $224.88M | +3.5% |
| Q3 FY2020 | Sep 30, 2020 | $208.32M | -1.1% |
| Q2 FY2020 | Jun 30, 2020 | $174.40M | -14.7% |
| Q1 FY2020 | Mar 31, 2020 | $209.81M | +5.2% |
| Q4 FY2019 | Dec 31, 2019 | $217.22M | +15.5% |
| Q3 FY2019 | Sep 30, 2019 | $210.65M | +16.6% |
| Q2 FY2019 | Jun 30, 2019 | $204.48M | +13.0% |
| Q1 FY2019 | Mar 31, 2019 | $199.36M | +9.8% |
| Q4 FY2017 | Dec 31, 2017 | $188.00M | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $180.65M | – |
| Q2 FY2017 | Jun 30, 2017 | $180.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $181.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $183.63M | – |
See a number that looks wrong?